|
Patient- and Physician-Based Osteoporosis Education Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Patient- and Physician-Based Osteoporosis Education conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Patient- and Physician-Based Osteoporosis Education Clinical research trials and Patient- and Physician-Based Osteoporosis Education medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Patient- and Physician-Based Osteoporosis Education. Patient- and Physician-Based Osteoporosis Education Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Patient- and Physician-Based Osteoporosis Education clinical trial. Participants frequently obtain the most expert healthcare available for their Patient- and Physician-Based Osteoporosis Education condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Patient- and Physician-Based Osteoporosis Education  Patient- and Physician-Based Osteoporosis Education
Patient- and Physician-Based Osteoporosis Education
For Condition: Osteoporosis,Osteoporosis, Postmenopausal
Status: No longer recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) , Arthritis Foundation
Synopsis: Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment of osteoporosis.
Details: Osteoporosis affects a large and growing proportion of the population. Multiple drugs for the prevention and treatment of osteoporosis have been developed, tested, and proven effective in the last decade. However, these drugs may not always be adequately prescribed. Several effective nonpharmacological measures also exist for preventing fractures; strength and gait training, home safety modifications, and other lifestyle modifications have all been shown in carefully conducted trails to reduce the risk of falls that lead to osteoporotic factures. Yet these interventions are under-utilized. Practical public health strategies are needed to bring these experimental findings to widespread use in typical populations of at-risk patients. This study will evaluate innovative fracture prevention interventions targeted to both patients and doctors. Specifically, the study will compare the effects of the patient and physician behavior change intervention alone and in combination on prescribing patterns for osteoporosis therapies and will examine the interventions' effects on fracture prevention behaviors other than medication use. The patient intervention will consist of two mailings and will be targeted using clinical and demographic data from the State of Pennsylvania's Pharmaceutical Assistance Contract for the Elderly (PACE) and Medicare databases. The first mailing will introduce the topic of osteoporosis and explain why osteoporosis is an important topic for all those receiving the mailing. The second mailing, sent the following month, will reinforce the first mailing and contain patient-specific information based on demographic and clinical factors. This mailing will also focus on several proven prevention strategies, including strength and gait training, vision care, home safety improvements, calcium intake, and pharmaceutical enhancement of bone density. The physician intervention will be multifaceted and will include a mailed practice audit and one-on-one education through academic detailing. The mail audit will contain information on the physician’s PACE patients and an assessment of their osteoporosis risk based on clinical and drug data. Following the mailing, an academic detailer will meet with the physicians receiving the intervention. Outcome measures will include questionnaires, medication use, Dual Energy X-ray Absorptiometry (DEXA) scans, and use of physical therapy.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: 65 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria For Patients: - PACE beneficiaries who filled at least one prescription for a drug of any type in the year prior to the study - At high risk for osteoporosis: women and men 75 years or older, patients taking glucocorticoids or psychoactive medications, patients diagnosed with rheumatoid arthritis, and patients with a past fracture - Have had an outpatient visit with a participating doctor based on Medicare outpatient claims Inclusion Criteria For Physicians: - Primary prescribing physicians for PACE beneficiaries
Total Enrollment: 30000
Location and Contact Information:
Overall Study Official:
DanielSolomon, Principal Investigator,
Daniel H. Solomon MD, MPH
Boston, Massachusetts, 02115
United States
Additional Information:
Study ID Numbers: NIAMS-074; K23 AR48616
Study Start Date: September 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073190
Other Osteoporosis Studies:
1. Patient- and Physician-Based Osteoporosis Education
2. Combined Use of Study Drug and a marketed SERM (Selective Estrogen Receptor Modulator) in Postmenopausal Women with Osteoporosis
Related Studies:
Other Osteoporosis Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Patient- and Physician-Based Osteoporosis Education
|
|
|
|
|
|
|
|
